BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33904576)

  • 1. pDriver: a novel method for unravelling personalized coding and miRNA cancer drivers.
    Pham VVH; Liu L; Bracken CP; Nguyen T; Goodall GJ; Li J; Le TD
    Bioinformatics; 2021 Oct; 37(19):3285-3292. PubMed ID: 33904576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DriverGroup: a novel method for identifying driver gene groups.
    Pham VVH; Liu L; Bracken CP; Goodall GJ; Li J; Le TD
    Bioinformatics; 2020 Dec; 36(Suppl_2):i583-i591. PubMed ID: 33381812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NIBNA: a network-based node importance approach for identifying breast cancer drivers.
    Chaudhary MS; Pham VVH; Le TD
    Bioinformatics; 2021 Sep; 37(17):2521-2528. PubMed ID: 33677485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PersonaDrive: a method for the identification and prioritization of personalized cancer drivers.
    Erten C; Houdjedj A; Kazan H; Taleb Bahmed AA
    Bioinformatics; 2022 Jun; 38(13):3407-3414. PubMed ID: 35579340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
    Zhang J; Liu L; Li J; Le TD
    Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
    Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
    PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network-based method for identifying cancer driver genes based on node control centrality.
    Li F; Li H; Shang J; Liu JX; Dai L; Liu X; Li Y
    Exp Biol Med (Maywood); 2023 Feb; 248(3):232-241. PubMed ID: 36573462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
    Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
    Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRODIGY: personalized prioritization of driver genes.
    Dinstag G; Shamir R
    Bioinformatics; 2020 Mar; 36(6):1831-1839. PubMed ID: 31681944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying driver genes for individual patients through inductive matrix completion.
    Zhang T; Zhang SW; Li Y
    Bioinformatics; 2021 Dec; 37(23):4477-4484. PubMed ID: 34175939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driver gene detection through Bayesian network integration of mutation and expression profiles.
    Chen Z; Lu Y; Cao B; Zhang W; Edwards A; Zhang K
    Bioinformatics; 2022 May; 38(10):2781-2790. PubMed ID: 35561191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.
    Lee E; Ito K; Zhao Y; Schadt EE; Irie HY; Zhu J
    Bioinformatics; 2016 Jan; 32(1):96-105. PubMed ID: 26358730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural inductive matrix completion with graph convolutional networks for miRNA-disease association prediction.
    Li J; Zhang S; Liu T; Ning C; Zhang Z; Zhou W
    Bioinformatics; 2020 Apr; 36(8):2538-2546. PubMed ID: 31904845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying cancer-related microRNAs based on gene expression data.
    Zhao XM; Liu KQ; Zhu G; He F; Duval B; Richer JM; Huang DS; Jiang CJ; Hao JK; Chen L
    Bioinformatics; 2015 Apr; 31(8):1226-34. PubMed ID: 25505085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient framework to identify key miRNA-mRNA regulatory modules in cancer.
    Mokhtaridoost M; Gönen M
    Bioinformatics; 2020 Dec; 36(Suppl_2):i592-i600. PubMed ID: 33381822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A learning-based framework for miRNA-disease association identification using neural networks.
    Peng J; Hui W; Li Q; Chen B; Hao J; Jiang Q; Shang X; Wei Z
    Bioinformatics; 2019 Nov; 35(21):4364-4371. PubMed ID: 30977780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AEMDA: inferring miRNA-disease associations based on deep autoencoder.
    Ji C; Gao Z; Ma X; Wu Q; Ni J; Zheng C
    Bioinformatics; 2021 Apr; 37(1):66-72. PubMed ID: 32726399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New computational model for miRNA-mediated repression reveals novel regulatory roles of miRNA bindings inside the coding region.
    Bergman S; Diament A; Tuller T
    Bioinformatics; 2021 Apr; 36(22-23):5398-5404. PubMed ID: 33320173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and analysis of a survival-associated competing endogenous RNA network in breast cancer.
    Chen G; Li Y; Cao J; Dai Y; Cong Y; Qiao G
    Front Surg; 2022; 9():1021195. PubMed ID: 36684328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.